Effective Technology Transfer Strategies for Biologic- Drug Development

Article

To view a PDF of this article from the BioPharm International archives, click this link

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Feliza Mirasol
August 7th 2025
Article
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
August 7th 2025
Podcast
Doctor or scientist shows a vial of genetic agent as a vaccine or therapy against Corona or Covid-19 as a symbolic image | Image Credit: © Dan Race - stock.adobe.com

Reaction and Fallout as HHS ‘Winds Down’ mRNA Vaccine Development, Canceling $500 Million in Projects

Patrick Lavery
August 7th 2025
Article
Mastering Antibody-Drug Conjugates

Mastering Antibody-Drug Conjugates

BIOVECTRA
August 7th 2025
Podcast
bioreactor in the bio lab | Image Credit: ©luchschenF– Stock.Adobe.com

Single-Use Technology: Transforming Biomanufacturing Today and Tomorrow

Chris Chen
August 7th 2025
Article
B-cell, white blood cell 3D, type of lymphocyte interacting with a virus. Adaptive immune response, CAR-T cell therapy. B cell is humoral immunity component of the immune system producing antibodies | Image Credit: © Corona Borealis - stock.adobe.com

NanoCell’s LNP Platform Shows Promise for In-Vivo CAR-T Development

Patrick Lavery
August 7th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.